Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN951014 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Calumenin (CALU) (AA 216-246), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Affinity Chromatography on Protein A
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term, AA 216-246
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.
Hernández-Romero D, Ruiz-Nodar JM, Marín F, Tello-Montoliu A, Roldán V, Mainar L, Pérez-Andreu V, Antón AI, Bonaque JC, Valdés M, Vicente V, González-Conejero R
Annals of medicine 2010 Sep;42(6):439-46
Annals of medicine 2010 Sep;42(6):439-46
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S, DREAM investigators.
Diabetes care 2010 Oct;33(10):2250-3
Diabetes care 2010 Oct;33(10):2250-3
An evaluation of nine genetic variants related to metabolism and mechanism of action of warfarin as applied to stable dose prediction.
Carlquist JF, Horne BD, Mower C, Park J, Huntinghouse J, McKinney JT, Muhlestein JB, Anderson JL
Journal of thrombosis and thrombolysis 2010 Oct;30(3):358-64
Journal of thrombosis and thrombolysis 2010 Oct;30(3):358-64
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC